CHE

Business Context and Reporting Period

Company: Chemed Corporation
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 1997
Business Overview: Chemed operates primarily through two continuing segments: Roto-Rooter (plumbing and drain cleaning services) and Patient Care (home health care). The quarter was defined by the strategic divestiture of two major subsidiaries, Omnia Group and National Sanitary Supply Company, which are now classified as discontinued operations.

Key Financial Metrics

Note: Q3 1996 and 9-month 1996 figures are reclassified to reflect discontinued operations.

Material Changes vs. Prior Period

• Discontinued Operations Impact: Net income surged due to a net after-tax gain of $9.5 million in Q3 1997 from the sale of Omnia Group and National Sanitary Supply. This contrasts with Q3 1996, where discontinued operations contributed only $2.5 million from ongoing operations.
• Liquidity Transformation: Cash and cash equivalents increased by $117.5 million (from $14.0 million to $131.5 million) driven by $187.3 million in net proceeds from the sale of discontinued operations.
• Debt Reduction: Long-term debt decreased by approximately $67.8 million as proceeds from asset sales were used to repay borrowings.
• Continuing Operations Growth:
  • Roto-Rooter: Revenues increased 11% in Q3 and 9% for the nine-month period. Operating margins improved to 10.5% (Q3) and 9.4% (9 months).
  • Patient Care: Revenues increased 27% in Q3 and 22% for the nine-month period. However, operating margins declined to 5.0% (Q3) and 4.5% (9 months) due to market pricing pressures.
• Interest Expense: Increased significantly (41% in Q3, 53% for 9 months) due to borrowings incurred in late 1996 to purchase the minority interest in Roto-Rooter.

Guidance, Outlook, and Risks

• Divestiture Completion: The company successfully exited the medical/dental supplies (Omnia) and sanitary maintenance (National) businesses, receiving $50.7 million and $120.2 million respectively.
• Vitas Liquidity: Chemed's investment in Vitas (Patient Care segment) faces liquidity constraints. Vitas deferred preferred stock payments due to debt covenants preventing timely dividend payments. Management believes the investment is fully recoverable but is exploring long-term financing or a public offering for Vitas.
• Acquisitions: Chemed completed ten small business combinations in the Roto-Rooter and Patient Care segments for $8.9 million in cash during the first nine months of 1997.
• Tax Accruals: Income taxes payable increased to $40.5 million, largely due to the accrual of taxes on the gain from the sale of National. Approximately $25 million is due in December 1997.
• Capital Position: Management states that with $34.2 million in unused credit lines and strong cash reserves, liquidity is satisfactory for foreseeable needs.

Investor Verification Checklist

• Discontinued Operations: Verify the final tax implications and any remaining deferred payments related to the Omnia and National sales.
• Vitas Financial Health: Monitor the status of Vitas' preferred stock redemption and the progress of its potential public offering or refinancing.
• Patient Care Margins: Assess whether the decline in Patient Care operating margins (from 5.9% to 5.0% in Q3) is a temporary pricing pressure or a structural shift.
• Debt Covenants: Review the impact of the reduced debt load on future borrowing capacity and interest rate exposure.
• Acquisition Integration: Evaluate the performance of the ten new acquisitions completed in the first nine months of 1997.